$NBIO - Nascent Biotech Granted Japanese Patent for Crossing Blood-Brain Barrier. The patent allowance recognizes PTB's ability to act as a monotherapy, as well as its potential to act as a conjugate, bringing other therapies across the BBB. https://finance.yahoo.com/news/nascent-biotech-granted-japanese-patent-130000461.html